| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/25/2012 | EP1412379B1 Vaccine |
| 01/25/2012 | CN102333776A Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
| 01/25/2012 | CN102333769A Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 01/25/2012 | CN102333537A Methods of treating retinitis pigmentosa |
| 01/25/2012 | CN102333527A Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa |
| 01/25/2012 | CN102327453A Chinese herbal medicine for treating hordeolum |
| 01/25/2012 | CN102327394A Chinese herbal medicine for treating photophobia |
| 01/25/2012 | CN102327393A Chinese medicinal herb for treating aural vertigo |
| 01/25/2012 | CN102327379A Traditional Chinese medicine for treating diabetic retinopathy |
| 01/25/2012 | CN102327375A Chinese herbal medicine for treating eye congestion |
| 01/25/2012 | CN102327356A Chinese medicinal herb for treating tearing against wind |
| 01/25/2012 | CN102327334A Chinese medicine for dispelling wind and arresting itching and treating conjunctivitis and preparation method thereof |
| 01/25/2012 | CN102327333A Chinese medicine for treating eye diseases caused by exogenous wind pathogen and preparation method thereof |
| 01/25/2012 | CN102327213A Triamcinolone acetonaide acetate nano eye drops and preparation method thereof |
| 01/25/2012 | CN102327210A Vinpocetine suspension injection |
| 01/25/2012 | CN102327014A Bayberry pillow |
| 01/25/2012 | CN101972340B Traditional Chinese medicine composition for tonifying liver and improving eyesight |
| 01/25/2012 | CN101953950B Chinese medicament for treating viral keratitis |
| 01/25/2012 | CN101244126B Composition for treating eye disease and preparation method |
| 01/24/2012 | US8101635 Use of glutamate antagonists which is a NMDA receptor antagonist ( ifenprodil, memantine) to reduce or control retinal pigment epithelium and/or glial migration and the subsequent development of proliferative vitreoretinopathy ( vision defect ) |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | CA2528010C 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2462857C Angiotensin peptide-carrier conjugates and uses thereof |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/19/2012 | WO2012009471A1 Anti-angiogenic agent and method of using such agent |
| 01/19/2012 | WO2012009171A2 Compositions and methods of treatment of corneal endothelium disorders |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012007777A1 Novel proteins, process for preparation thereof, and use thereof |
| 01/19/2012 | WO2012006960A1 NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011112243A3 Beta -adrenergic receptor agonists and uses thereof |
| 01/19/2012 | WO2011087491A9 Parstatin peptides and uses thereof |
| 01/19/2012 | US20120016467 Polymer-based, sustained release drug delivery system |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016030 Methoxypolyethylene glycol thioester chelate and uses thereof |
| 01/19/2012 | US20120016027 Composition and Method for Improved Lens Comfort |
| 01/19/2012 | US20120016020 Solid dispersion of alpha-ketoamide derivatives |
| 01/19/2012 | US20120016016 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 01/19/2012 | US20120015999 Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015978 Therapeutic agents for ocular hypertension |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015971 Ophthalmic composition comprising ascomycin |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015961 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
| 01/19/2012 | US20120015953 Methods and compositions for the treatment of allergy |
| 01/19/2012 | US20120015951 Polymorphs of Brimonidine Pamoate |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015912 Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| 01/19/2012 | US20120015911 Method and compositions for treating amyloid-related diseases |
| 01/19/2012 | US20120015884 Polypeptides for Specific Targeting to Otx2 Target Cells |
| 01/19/2012 | US20120015055 Composition and method for controlling the respiratory effects of inhaled pollutants and allergens |
| 01/19/2012 | US20120015035 Implantable Delivery Vehicle for Ocular Delivery of Muscarinic Antagonists |
| 01/19/2012 | US20120015001 Methods of treating thyroid eye disease |
| 01/19/2012 | US20120014974 Methods of modulating cell death based on the bit1/aes regulatory pathway |
| 01/19/2012 | US20120014970 Therapeutic Compositions for Treatment of Corneal Disorders |
| 01/19/2012 | US20120014967 Il-1beta binding antibodies and fragments thereof |
| 01/19/2012 | US20120014966 Methods for the treatment of il-1beta related conditions |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014954 Sparc binding scfvs |
| 01/19/2012 | US20120014936 Methods and compositions for cns delivery of heparan n-sulfatase |
| 01/19/2012 | CA2805148A1 Novel fused heterocyclic derivatives useful as c-met tyrosine kinase inhibitors |
| 01/19/2012 | CA2804753A1 Anti-angiogenic agent and methods of using such agent |
| 01/18/2012 | EP2407476A1 Steroid compound |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407454A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
| 01/18/2012 | EP2407171A2 Compositions and methods for the treatment of ophthalmic disease |
| 01/18/2012 | EP2405882A1 Complex of polymeric quaternary ammonium and anionic polymers as a new antimicrobial agent for ophthalmic compositions |
| 01/18/2012 | EP1827403B1 Compositions for treating surface ocular pathologies |
| 01/18/2012 | EP1814532B1 Topical application of muscarinic and opioid agents for treatment of tinnitus |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | CN102325566A Selective histamine h4 receptor antagonists for the treatment of vestibular disorders |
| 01/18/2012 | CN102325550A Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature |
| 01/18/2012 | CN102319432A Ocular implant made by a double extrusion process |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319400A Traditional Chinese drug composition for blood cooling, hemostasis, yin nourishing, blood stasis dissipating, liver nourishing and eyesight improving, and preparation method thereof |
| 01/18/2012 | CN102319398A Blood-nourishing and eyesight-improving Chinese medicinal composition and preparation method thereof |
| 01/18/2012 | CN102319364A Manufacturing method of dendrobium candidum wallex lindll pure powder tablets |
| 01/18/2012 | CN102319333A Sheep liver eyesight improving pill and processing method thereof |
| 01/18/2012 | CN102319323A Eyedrop for reducing intraocular pressure and treating glaucoma and preparation method thereof |
| 01/18/2012 | CN102319239A Application of ainsliaidimer A in preparing nucleolus transcription factor inhibitor medicament |
| 01/18/2012 | CN102319204A Azithromycin ophthalmic preparation drug composition and preparation method thereof |
| 01/17/2012 | US8097649 Composition and method for stabilizing the same |
| 01/17/2012 | US8097640 Prophylactic or therapeutic agent for diabetic maculopathy |
| 01/17/2012 | US8097600 Method of increasing tear production with purinergic receptor agonists |
| 01/17/2012 | US8097270 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 01/17/2012 | US8097254 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/17/2012 | US8096972 Devices for intraocular drug delivery |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2429998C Intraocular implants for preventing transplant rejection in the eye |
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/12/2012 | WO2012006083A2 Targeted receptor-mediated sirna |
| 01/12/2012 | WO2012005311A1 Composition for contact lens care |